RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Ondansetron

Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, Prevention of nausea and vomiting associated with moderately emetogenic cancer..., Prevention of nausea and vomiting associated with radiotherapy, Prevention of postoperative nausea and/or vomiting

Indications

  • Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy
  • Prevention of nausea and vomiting associated with moderately emetogenic cancer...
  • Prevention of nausea and vomiting associated with radiotherapy
  • Prevention of postoperative nausea and/or vomiting

Adult dosing

  • highly emetogenic chemo: dose: 24; unit: mg; route: PO; interval: single dose 30 minutes before; fixed: true; labelExcerpt: A single 24 mg dose administered 30 minutes before the start of single-day highly emetogenic chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 .
  • moderately emetogenic chemo: dose: 8; unit: mg; route: PO; interval: 30 minutes before, then 8 mg 8 hours after, then 8 mg twice daily for 1 to 2 days; fixed: true; labelExcerpt: 8 mg administered 30 minutes before the start of chemotherapy, with a subsequent 8 mg dose 8 hours after the first dose. Then administer 8 mg twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
  • radiotherapy: dose: 8; unit: mg; route: PO; interval: 1 to 2 hours before radiotherapy, then every 8 hours; fixed: true; labelExcerpt: 8 mg administered 1 to 2 hours before radiotherapy, with subsequent 8 mg doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
  • postoperative: dose: 16; unit: mg; route: PO; interval: 1 hour before induction of anesthesia; fixed: true; labelExcerpt: 16 mg administered 1 hour before induction of anesthesia.

Pediatric dosing

  • moderately emetogenic chemo 12 1: dose: 8; unit: mg; route: PO; interval: 30 min before, then 8 mg 8 hrs later, then 8 mg BID for 1-2 days; fixed: true; labelExcerpt: 12 to 17 years of age: 8 mg administered 30 minutes before the start of chemotherapy, with a subsequent 8 mg dose 8 hours after the first dose. Then administer 8 mg twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
  • moderately emetogenic chemo 4 11: dose: 4; unit: mg; route: PO; interval: 30 min before, then 4 mg at 4 and 8 hrs, then 4 mg TID for 1-2 days; fixed: true; labelExcerpt: 4 to 11 years of age: 4 mg administered 30 minutes before the start of chemotherapy, with a subsequent 4 mg dose 4 and 8 hours after the first dose. Then administer 4 mg three times a day for 1 to 2 days after completion of chemotherapy.

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • In severe hepatic impairment (Child-Pugh score >= 10), do not exceed 8 mg/day.

Contraindications

  • Hypersensitivity to ondansetron
  • Concomitant apomorphine use

Clinical pearls

  • Monitor for QT interval prolongation and consider ECGs in high-risk patients.
  • Be aware of the risk of serotonin syndrome, especially with other serotonergic medications.
  • Monitor for signs of myocardial ischemia after administration.
  • Ondansetron can mask signs of progressive ileus after abdominal surgery.

Source and review

  • DailyMed label (ondansetron hydrochloride), Set ID 14276805-4e99-4bbe-ad76-ffc06eddb38a, effective 2026-10-09. Last reviewed: 2026-11-11